Barclays Has Lowered Expectations for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN - Get Free Report) had its price target decreased by stock analysts at Barclays from $83.00 to $79.00 in a research report issued on Monday,Benzinga reports. The firm presently has an "overweight" rating on the stock. Barclays's price objective indicates a potential upside of 19.50% from the stock's previous close.

A number of other research firms have also recently weighed in on RYAN. Wells Fargo & Company lowered their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. TD Cowen assumed coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target on the stock. Morgan Stanley raised their price target on shares of Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a report on Monday, May 19th. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Finally, The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and raised their price target for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $75.25.

Ryan Specialty Trading Up 0.2%

RYAN stock traded up $0.12 during trading on Monday, hitting $66.11. The company had a trading volume of 1,244,343 shares, compared to its average volume of 922,080. The firm has a market capitalization of $17.35 billion, a P/E ratio of 194.44, a PEG ratio of 1.77 and a beta of 0.66. Ryan Specialty has a 52-week low of $55.67 and a 52-week high of $77.16. The company has a 50 day simple moving average of $68.13 and a 200-day simple moving average of $68.12. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 3.45.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting the consensus estimate of $0.39. The company had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. The firm's revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.35 EPS. As a group, research analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total transaction of $354,000.00. Following the completion of the sale, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the transaction, the executive vice president directly owned 1,117 shares of the company's stock, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.

Institutional Investors Weigh In On Ryan Specialty

Several institutional investors and hedge funds have recently added to or reduced their stakes in RYAN. Raymond James Financial Inc. purchased a new stake in Ryan Specialty in the 4th quarter worth $94,484,000. Norges Bank purchased a new stake in Ryan Specialty in the 4th quarter worth $78,358,000. Principal Financial Group Inc. increased its holdings in Ryan Specialty by 66.4% in the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock worth $225,404,000 after acquiring an additional 1,218,147 shares in the last quarter. Millennium Management LLC increased its holdings in Ryan Specialty by 1,111.4% in the 4th quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock worth $75,329,000 after acquiring an additional 1,077,169 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in Ryan Specialty by 121.6% in the 1st quarter. Invesco Ltd. now owns 1,590,862 shares of the company's stock worth $117,517,000 after acquiring an additional 872,846 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.